Compare SPT & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPT | AMPH |
|---|---|---|
| Founded | 2010 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 553.4M | 1.3B |
| IPO Year | 2019 | 2014 |
| Metric | SPT | AMPH |
|---|---|---|
| Price | $9.91 | $27.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 6 |
| Target Price | $26.00 | ★ $35.17 |
| AVG Volume (30 Days) | ★ 1.5M | 479.9K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.27 |
| Revenue | $443,750,000.00 | ★ $723,305,000.00 |
| Revenue This Year | $13.14 | $0.74 |
| Revenue Next Year | $11.85 | $5.63 |
| P/E Ratio | ★ N/A | $12.21 |
| Revenue Growth | ★ 13.09 | N/A |
| 52 Week Low | $9.16 | $20.39 |
| 52 Week High | $36.30 | $46.11 |
| Indicator | SPT | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 42.89 | 62.39 |
| Support Level | $9.74 | $24.92 |
| Resistance Level | $10.14 | $27.83 |
| Average True Range (ATR) | 0.58 | 1.20 |
| MACD | 0.09 | 0.21 |
| Stochastic Oscillator | 34.40 | 74.94 |
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.